Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States
2016
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Ferroptosis: past, present and future
2020 Standout
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
mRECIST for HCC: Performance and novel refinements
2020
Surveillance for Hepatocellular Carcinoma and Early Diagnosis
2007
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
2016
Burden of liver diseases in the world
2018 Standout
Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy—A Systematic Review
2018
Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma
2019
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
2017
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
2017
One preoperative dose randomized against 3‐day antibiotic prophylaxis for transrectal ultrasonography‐guided prostate biopsy
2008
Systematic Review of Complications of Prostate Biopsy
2013
Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10–20 mm) detected in the cirrhotic liver at screening ultrasound
2017
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Gastrointestinal Stromal Tumors
2009
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
2015
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
2017
Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade
2016
The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma
2016
Cisplatin Nephrotoxicity: A Review
2007 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
2019
Liver Imaging Reporting and Data System v2014 With Gadoxetate Disodium–Enhanced Magnetic Resonance Imaging
2016
Transarterial radioembolizationvschemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis
2016
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
2017
Comparison of a 3‐day with a 1‐day regimen of an extended‐release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate
2007
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
2017
Pyroptosis: mechanisms and diseases
2021 Standout
Liver cancer: Approaching a personalized care
2015
Hepatitis C virus infection
2017
Chronic hepatitis B
2007 Standout
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
2016
Chronic hepatitis B: Update 2009 #
2009 Standout
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Systemic treatment of hepatocellular carcinoma: An EASL position paper
2021
Global burden of liver disease: 2023 update
2023 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Effect of HCV clearance with direct-acting antiviral agents on HCC
2016
Sarcoidosis: The Nephrologist’s Perspective
2006
Hepatitis C Virus E2 Envelope Glycoprotein Induces an Immunoregulatory Phenotype in Macrophages
2018
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
2020
Extragastrointestinal (Soft Tissue) Stromal Tumors: An Analysis of 48 Cases with Emphasis on Histologic Predictors of Outcome
2000 Standout
Molecular therapies and precision medicine for hepatocellular carcinoma
2018
Methods for assessing intrahepatic fat content and steatosis
2009
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
2016
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
2021
Clinical states of cirrhosis and competing risks
2017
Sarcoidosis
2007 Standout
Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI
2017
Hepatocellular Carcinoma
2011 Standout
Natural history of liver imaging reporting and data system category 4 nodules in MRI
2016
Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus
2019 StandoutNobel
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
2015
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging
2016
Anticancer Drug???Induced Kidney Disorders
2001
Hepatocellular carcinoma
2022 Standout
Chronic viral hepatitis and its association with liver cancer
2017
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sigma‐1 receptor protects against ferroptosis in hepatocellular carcinoma cells
2019
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
The oncologic burden of hepatitis C virus infection: A clinical perspective
2017
Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5
2017
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
2020
Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS
2017
Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018
2019
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Black‐Phosphorus‐Incorporated Hydrogel as a Sprayable and Biodegradable Photothermal Platform for Postsurgical Treatment of Cancer
2018
The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
2018
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Works of Anna Darnell being referenced
[Nephropathy by sarcoid granulomas].
1978
Gastrointestinal stromal tumors
2006
Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis
2002
Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
1998
Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib
2014
Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US
2015
Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?
2006
Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines
2018
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
2016
Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second-line trial design
2013
Acute renal failure associated with alpha-interferon therapy for chronic hepatitis B
1995
Systemic Therapy for Hepatocellular Carcinoma: The Issue of Treatment Stage Migration and Registration of Progression Using the BCLC-Refined RECIST
2014